Skip to content

A study on prognosis prediction of Patients with renal cell Carcinoma Based on Clinical data

A study on prognosis prediction of Patients with renal cell Carcinoma Based on Clinical data

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126536
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear cell renal cell carcinoma

Interventions

Clinical sample cohort of patients with clear cell renal cell carcinoma (ccRCC):No

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above, no gender restriction; 2. It was confirmed as renal cell carcinoma by pathology or imaging; 3. Have complete clinical data, such as age, gender, tumor stage, etc; 4. Have relevant prognostic follow-up information;

Exclusion criteria

Exclusion criteria: 1. Those with concurrent other malignant tumors; 2. Those with concurrent other malignant tumors; 3. Those with severe organ dysfunction or serious diseases that affect prognosis judgment (such as severe heart, liver, brain, and lung diseases); 4. Those who are unwilling to participate in the research or withdraw halfway; 5. Other patients who were determined by the research team to be unsuitable for inclusion;

Design outcomes

Primary

MeasureTime frame
Progression-Free Interval (PFI);Overall Survival (OS);Area under the curve (AUC);

Countries

China

Contacts

Public ContactZhifeng Wang

Henan Provincial People's Hospital

shengyiwzf@zzu.edu.com+86 371 6558 0658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026